| 摘要 |
The present invention relates to substituted 5-phenyl pyrimidines I, which carry a radical X in the 4-position of the pyrimidine ring, a radical Y in the 6-position of the pyrimidine ring, the radical X denoting a group of the formula NRR, in which Ris C-C-alkyl, C-C-alkenyl, C-C-haloalkyl, C-C-cycloalkyl, which can be substituted by C-C-alkyl, Ris H, C-C-alkyl or C-C-alkenyl, radical Y is selected from a group comprising halogen and C-C-alkyl and pharmaceutically acceptable salts substituted 5-phenyl pyrimidines I for use in therapy or treatment cancerous diseases. |
